Trial
NCT05951296
A Study to Investigate Leramistat in Patients With IPF
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Modern Biosciences Ltd
Collaborators
—
Condition
Idiopathic Pulmonary Fibrosis
Intervention
Leramistat
Why stopped
Due to slow initial recruitment and a lack of confidence in our ability to complete recruitment within the forecasted timeframe.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-04-09